A detailed history of Allspring Global Investments Holdings, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 453,742 shares of ABBV stock, worth $82.2 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
453,742
Previous 519,544 12.67%
Holding current value
$82.2 Million
Previous $89.1 Million 0.55%
% of portfolio
0.14%
Previous 0.15%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$163.84 - $199.33 $10.8 Million - $13.1 Million
-65,802 Reduced 12.67%
453,742 $89.6 Million
Q2 2024

Jul 26, 2024

BUY
$154.79 - $180.76 $1.34 Million - $1.57 Million
8,679 Added 1.7%
519,544 $89.1 Million
Q1 2024

Apr 18, 2024

BUY
$159.82 - $182.1 $889,717 - $1.01 Million
5,567 Added 1.1%
510,865 $93 Million
Q4 2023

Jan 25, 2024

BUY
$137.6 - $154.97 $14.9 Million - $16.8 Million
108,484 Added 27.34%
505,298 $78.3 Million
Q3 2023

Oct 27, 2023

BUY
$133.59 - $154.65 $53 Million - $61.4 Million
396,814 New
396,814 $59.1 Million
Q2 2023

Jul 18, 2023

SELL
$132.51 - $164.9 $30.9 Million - $38.5 Million
-233,365 Reduced 38.23%
377,000 $50.8 Million
Q1 2023

Apr 13, 2023

SELL
$144.61 - $166.54 $21.7 Million - $25 Million
-150,223 Reduced 19.75%
610,365 $97.3 Million
Q4 2022

Jan 23, 2023

SELL
$138.31 - $165.87 $47.2 Million - $56.6 Million
-341,456 Reduced 30.98%
760,588 $0
Q3 2022

Oct 26, 2022

SELL
$134.21 - $153.93 $31.7 Million - $36.4 Million
-236,261 Reduced 17.65%
1,102,044 $148 Million
Q2 2022

Jul 25, 2022

SELL
$137.62 - $174.96 $54.3 Million - $69 Million
-394,641 Reduced 22.77%
1,338,305 $205 Million
Q1 2022

May 02, 2022

SELL
$131.98 - $163.75 $37.3 Million - $46.2 Million
-282,335 Reduced 14.01%
1,732,946 $281 Million
Q4 2021

Jan 28, 2022

BUY
$107.43 - $135.93 $217 Million - $274 Million
2,015,281 New
2,015,281 $273 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.